Overview

Study Evaluating Sirolimus in Kidney Transplant Recipients.

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Renal function at 12 months assessed by calculated creatinine clearance.
Phase:
Phase 3
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Cyclosporine
Cyclosporins
Everolimus
Sirolimus